BCPP flashcards
BCPP · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- PHQ-9 Severity Cutoffs
- The Patient Health Questionnaire-9 scores 5-9 as mild, 10-14 moderate, 15-19 moderately severe, and 20-27 severe depression; a score of 10 or more suggests clinically significant major depression.
- CIWA-Ar Treatment Threshold
- The Clinical Institute Withdrawal Assessment for Alcohol-Revised scores 0-67; 8-15 indicates moderate withdrawal usually treated with benzodiazepines, and 16 or higher indicates severe withdrawal with seizure and delirium risk.
- AIMS Abnormal Score
- The Abnormal Involuntary Movement Scale rates 7 items from 0 to 4; a score of 2 or more on one item or 3 or more on two items is abnormal and warrants further tardive dyskinesia evaluation.
- MDQ Positive Screen
- The Mood Disorder Questionnaire screens for bipolar disorder and is positive when the patient endorses 7 or more of 13 symptoms, reports co-occurrence, and rates the resulting problem as moderate or serious.
- C-SSRS High-Risk Items
- The Columbia Suicide Severity Rating Scale grades ideation severity from 1 to 5; endorsement of active ideation with some intent (item 4) or with a plan (item 5) indicates high acute risk.
- Lithium Level Sampling Time
- Serum lithium is drawn as a trough 12 hours after the last dose; the maintenance range is 0.6-1.2 mEq/L, and levels above 1.5 mEq/L are associated with clinically significant toxicity.
- Treatment-Resistant Depression Definition
- Major depression is treatment resistant after failure of at least two adequate antidepressant trials, each using a therapeutic dose for 4-8 weeks with adherence verified.
- Clozapine Indication in Schizophrenia
- Clozapine is indicated for schizophrenia that has failed at least two different antipsychotics at adequate dose and duration, and for reducing recurrent suicidal behavior in schizophrenia or schizoaffective disorder.
- First-Line Alcohol Use Disorder Drugs
- Naltrexone (oral 50 mg daily or 380 mg intramuscular monthly) and acamprosate 666 mg three times daily are first-line for alcohol use disorder; disulfiram is second-line and requires abstinence and supervision.
- OCD SSRI Trial Duration
- Obsessive-compulsive disorder generally requires higher SSRI doses and a trial of 8-12 weeks before judging response, followed by at least 1-2 years of continued treatment after response.
- Bipolar Antidepressant Monotherapy Risk
- Antidepressant monotherapy is avoided in bipolar I disorder because of treatment-emergent mania and rapid cycling; lithium, valproate, or second-generation antipsychotics are preferred as mood stabilizers.
- Buprenorphine First-Line for OUD
- Buprenorphine-naloxone and methadone are first-line for opioid use disorder and both reduce mortality; buprenorphine's partial agonism produces a ceiling effect on respiratory depression.
- Clozapine Neutrophil Monitoring Schedule
- Absolute neutrophil count is checked weekly for 6 months, every 2 weeks for the next 6 months, then monthly for the duration of clozapine therapy; mild neutropenia requires twice-weekly monitoring.
- Serotonin Syndrome Hunter Criteria
- Serotonin syndrome is diagnosed when a serotonergic drug is used plus one of: spontaneous clonus, inducible clonus with agitation, ocular clonus with agitation, tremor with hyperreflexia, or hyperthermia with rigidity.
- Neuroleptic Malignant Syndrome Features
- Neuroleptic malignant syndrome presents with hyperthermia, lead-pipe rigidity, altered mental status, and autonomic instability with elevated creatine kinase; management is stopping the antipsychotic plus dantrolene or bromocriptine.
- Citalopram QT Dose Limits
- Citalopram is limited to 40 mg/day in adults because of dose-dependent QT prolongation, and to 20 mg/day in patients over 60 years, with hepatic impairment, or who are CYP2C19 poor metabolizers.
- Valproate Teratogenicity Risk
- First-trimester valproate exposure carries roughly a 1-2% risk of neural tube defects, plus higher risks of other malformations and reduced IQ, so it is avoided in pregnancy when alternatives exist.
- Carbamazepine HLA-B*1502 Screening
- Patients of Asian ancestry should be screened for HLA-B*1502 before starting carbamazepine because the allele strongly predicts Stevens-Johnson syndrome and toxic epidermal necrolysis.
- SSRI Discontinuation Syndrome Risk
- Abrupt SSRI or SNRI discontinuation can cause dizziness, paresthesias, insomnia, and irritability; risk is highest with paroxetine and venlafaxine, so tapering over weeks is recommended.
- Aripiprazole Long-Acting Injection Overlap
- Aripiprazole long-acting injectable requires 14 consecutive days of overlapping oral aripiprazole after the first injection because the depot takes about 2 weeks to reach therapeutic exposure.
- Lurasidone Food Requirement
- Lurasidone should be taken with at least 350 calories of food; dosing on an empty stomach reduces absorption by roughly half and can lower efficacy.
- MAOI Tyramine-Restricted Diet
- Patients taking monoamine oxidase inhibitors must avoid aged cheese, cured meats, tap beer, soy sauce, and fermented foods to prevent tyramine-induced hypertensive crisis.
- Proportion of Days Covered
- Proportion of days covered is a refill-based adherence measure; a value of 80% or higher is generally used as the threshold for adequate adherence in chronic disease.
- SBAR Handoff Structure
- SBAR is a structured communication tool standing for Situation, Background, Assessment, and Recommendation, used to convey clinical information concisely during handoffs and interprofessional escalation.
- Collaborative Practice Agreement Definition
- A collaborative practice agreement is a written protocol allowing a pharmacist to initiate, modify, or discontinue specified drug therapy under defined conditions and prescriber oversight; scope varies by state law.
- 42 CFR Part 2 Protections
- 42 CFR Part 2 is stricter than HIPAA for substance use disorder treatment records, requiring specific written patient consent before disclosure and prohibiting redisclosure without new consent.
- BCPP Recertification Cycle
- Board Certified Psychiatric Pharmacist credentials are awarded by the Board of Pharmacy Specialties and must be renewed every 7 years through examination or approved continuing education.
- Just Culture Error Reporting
- Just culture distinguishes human error, at-risk behavior, and reckless behavior so that systems are corrected and errors are reported without punitive response, improving medication safety.
- Number Needed to Treat Formula
- Number needed to treat equals 1 divided by the absolute risk reduction, where absolute risk reduction is the control event rate minus the treatment event rate.
- Sensitivity Definition
- Sensitivity is true positives divided by true positives plus false negatives; it is the proportion of people who have the disease and are correctly identified by the test.
- Intention-to-Treat Principle
- Intention-to-treat analysis includes all randomized participants in their assigned group regardless of adherence or crossover, preserving randomization and avoiding bias from selective dropout.
- Odds Ratio Versus Risk Ratio
- An odds ratio approximates the risk ratio only when the outcome is rare, generally under 10%; for common outcomes the odds ratio exaggerates the effect and the risk ratio should be used.